GLPL Shareholding: Promoter, FII, DII, MF, Pledge

Promoters hold 57.3% of Goldline Pharmaceutical Ltd (GLPL). FIIs hold 5.2%, mutual funds 0.0% and other DIIs 7.8%. No promoter pledge is reported. Quarterly shareholding, quarter ended Mar 26.

Composition — Mar 26

Promoters 57.3%

Retail & others 29.7%

Promoters57.3%— first disclosure

FII5.2%— first disclosure

MF0.0%— first disclosure

Other DII7.8%— first disclosure

Retail & others29.7%— first disclosure

Institutional ownershipFII + MF + DII

13.0%

First disclosure — the trend begins next quarter.

Shareholder countfolios

Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.

Holders above 1% of equityevery person or company above 1% · shareholding pattern annexure

SWAPAN KHANDELWALIndividual / HUF

28.65%0.3 Cr

AMOL LAXMIKANT MUJUMDARIndividual / HUF

28.65%0.3 Cr

SUMIT BILGAIYANIndividual / HUF

7.03%0.1 Cr

UPSURGE OPPORTUNITIES FUND 1AIF

3.91%0.0 Cr

VIKASA INDIA EIF I FUND- SHARE CLASS PFII / Foreign

3.81%0.0 Cr

PRIYA CHANDRAKANT JALGAONKARIndividual / HUF

2.34%0.0 Cr

SGMP MANAGEMENT CONSULTANCY PRIVATE LIMITEDBody corporate

1.98%0.0 Cr

M/S NIRMAN SHARE BROKERS PVT. LTD. - PRO ACCOUNT-PROPOther

1.44%0.0 Cr

MEENA NAYAN PATELIndividual / HUF

1.04%0.0 Cr

Bulk & block dealsdisclosed exchange deals · trailing 90 days

PRIYA KABRA1 Sep 26 · bulk

BUY

₹0.21 Cr51,000 sh

PRIYA KABRA1 Sep 26 · bulk

SELL

₹0.21 Cr51,000 sh

AMOL LAXMIKANT MUJUMDAR31 Aug 26 · bulk

BUY

₹0.25 Cr60,000 sh

VEER SINGH THAKUR31 Aug 26 · bulk

SELL

₹0.25 Cr60,000 sh

SWAPAN KHANDELWAL28 Aug 26 · bulk

BUY

₹0.32 Cr78,000 sh

KAILASH KABRA25 Aug 26 · bulk

BUY

₹0.39 Cr96,000 sh

KAILASH KABRA25 Aug 26 · bulk

SELL

₹0.38 Cr96,000 sh

AJIT SINGH25 Aug 26 · bulk

BUY

₹0.24 Cr60,000 sh

VEER SINGH THAKUR25 Aug 26 · bulk

BUY

₹0.2 Cr51,000 sh

CUMULATIVE CAPITAL PRIVATE LIMITED25 Aug 26 · bulk

SELL

₹0.2 Cr51,000 sh

VEER SINGH THAKUR25 Aug 26 · bulk

SELL

₹0.01 Cr3,000 sh

UPSURGE OPPORTUNITIES FUND 124 Aug 26 · bulk

SELL

₹0.2 Cr51,000 sh

CUMULATIVE CAPITAL PRIVATE LIMITED24 Aug 26 · bulk

BUY

₹0.2 Cr51,000 sh

KAILASH KABRA21 Aug 26 · bulk

SELL

₹0.3 Cr72,000 sh

KAILASH KABRA21 Aug 26 · bulk

BUY

₹0.3 Cr72,000 sh

UPSURGE OPPORTUNITIES FUND 121 Aug 26 · bulk

SELL

₹0.21 Cr51,000 sh

SAMURAI SECURITIES PVT LTD21 Aug 26 · bulk

BUY

₹0.21 Cr51,000 sh

SAMURAI SECURITIES PVT LTD21 Aug 26 · bulk

SELL

₹0.21 Cr51,000 sh

UPSURGE OPPORTUNITIES FUND 120 Aug 26 · bulk

SELL

₹0.21 Cr51,000 sh

ANIL KUMAR RELAN (HUF)19 Aug 26 · bulk

BUY

₹0.48 Cr1,20,000 sh

VIKASA INDIA EIF I FUND-SHARE CLASS P19 Aug 26 · bulk

SELL

₹0.45 Cr1,14,000 sh

VIKASA INDIA EIF I FUND - SHARE CLASS P19 Aug 26 · bulk

SELL

₹0.26 Cr66,000 sh

ANIL KUMAR RELAN19 Aug 26 · bulk

BUY

₹0.24 Cr60,000 sh

PRIYA KABRA6 Aug 26 · bulk

SELL

₹0.32 Cr78,000 sh

PRIYA KABRA6 Aug 26 · bulk

BUY

₹0.32 Cr78,000 sh

AVIRAT ENTERPRISE6 Aug 26 · bulk

BUY

₹0.26 Cr63,000 sh

AVIRAT ENTERPRISE6 Aug 26 · bulk

SELL

₹0.02 Cr6,000 sh

AMJAY IMPEX PRIVATE LIMITED28 Jul 26 · bulk

SELL

₹0.5 Cr1,50,000 sh

PRIYA KABRA28 Jul 26 · bulk

BUY

₹0.27 Cr72,000 sh

PRIYA KABRA28 Jul 26 · bulk

SELL

₹0.27 Cr72,000 sh

VIRAL TILAK MARU28 Jul 26 · bulk

SELL

₹0.22 Cr57,000 sh

VIRAL TILAK MARU28 Jul 26 · bulk

BUY

₹0.19 Cr57,000 sh

AMJAY IMPEX PRIVATE LIMITED8 Jul 26 · bulk

BUY

₹0.63 Cr1,50,000 sh

BHAGWATI RADHESHYAM KHANDELWAL8 Jul 26 · bulk

SELL

₹0.25 Cr60,000 sh

BHAGWATI RADHESHYAM KHANDELWAL23 Jun 26 · bulk

BUY

₹0.64 Cr1,35,000 sh

UPSURGE OPPORTUNITIES FUND 123 Jun 26 · bulk

SELL

₹0.53 Cr1,11,000 sh

UPSURGE OPPORTUNITIES FUND 122 Jun 26 · bulk

SELL

₹0.31 Cr72,000 sh

SWAPAN KHANDELWAL22 Jun 26 · bulk

BUY

₹0.26 Cr60,000 sh

VIKASA INDIA EIF I FUND - SHARE CLASS P18 Jun 26 · bulk

SELL

₹0.66 Cr1,50,000 sh

AVIRAT ENTERPRISE17 Jun 26 · bulk

SELL

₹0.22 Cr51,000 sh

AVIRAT ENTERPRISE15 Jun 26 · bulk

SELL

₹0.36 Cr81,000 sh

AVIRAT ENTERPRISE10 Jun 26 · bulk

BUY

₹0.89 Cr1,80,000 sh

Insider & SAST disclosuresSEBI PIT / SAST filings · trailing 12 months

Mr. Amol Laxmikant Mujumdar31 Aug 26 · SAST · Reg 29(2) · Promoter · filing

BUY

60,000 sh— → 0.62%

Mr. Amol Laxmikant Mujumdar1 Sep 26 · SAST · Reg 29(2) · Promoter · filing

BUY

18,000 sh— → 0.19%

Amol Laxmikant Mujumdar1 Sep 26 · PIT · Reg 7(2) · Promoter and Director · filing

BUY

18,000 sh29.27% → 29.46%

Amol Laxmikant Mujumdar31 Aug 26 · PIT · Reg 7(2) · Promoter and Director · filing

BUY

60,000 sh28.64% → 29.27%

Details not machine-readable — see filing29 Aug 26 · SAST · Reg 29(2) · filing

—

qty not stated— → —

Mr. Swapan Khandelwal28 Aug 26 · SAST · Reg 29(2) · Promoter · filing

BUY

78,000 sh— → 0.81%

Swapan Khandelwal28 Aug 26 · PIT · Reg 7(2) · Promoter and Director · filing

BUY

78,000 sh29.27% → 30.08%

Mr. Prashant Shrikrishna Karkare28 Jul 26 · SAST · Reg 29(2) · Director · filing

BUY

27,000 sh— → 0.28%

Prashant Shrikrishna Karkare28 Jul 26 · PIT · Reg 7(2) · Director · filing

BUY

27,000 sh0.00% → 0.28%

Details not machine-readable — see filing24 Jun 26 · SAST · Reg 29(2) · filing

—

qty not stated— → —

Mr. Swapan Khandelwal22 Jun 26 · SAST · Reg 29(2) · Promoter · filing

BUY

60,000 sh— → 0.62%

Swapan Khandelwal22 Jun 26 · PIT · Reg 7(2) · Promoter & Director · filing

BUY

60,000 sh28.65% → 29.27%≈₹43.27/sh (from ₹25.96 L / 60,000 sh)

◆ What the data shows

Promoters hold 57.29% as of Mar 26.

Quarterly shareholding patternas of Mar 26

Frequently Asked Questions

What is the promoter holding in Goldline Pharmaceutical Ltd?: Promoters hold 57.3% of Goldline Pharmaceutical Ltd as of Q4 FY26, per the SEBI Reg-31 shareholding filing.
How much of Goldline Pharmaceutical Ltd do FIIs own?: Foreign institutional investors hold 5.2% of Goldline Pharmaceutical Ltd as of Q4 FY26.
How much of Goldline Pharmaceutical Ltd do domestic institutions own?: As of Q4 FY26, mutual funds 0.0%, other DIIs 7.8%.
What is retail holding in Goldline Pharmaceutical Ltd?: Retail public holds 29.7% of Goldline Pharmaceutical Ltd as of Q4 FY26, per the shareholding filing.